VA Telederm study: protocol for a stepped-wedge cluster randomised trial to compare access to care for a mobile app versus a workstation-based store-and-forward teledermatology process

Nicolae Done, Dennis H Oh, Martin A Weinstock, John D Whited, George L Jackson, Heather A King, Sara B Peracca, A Rani Elwy, Julia C Prentice, Nicolae Done, Dennis H Oh, Martin A Weinstock, John D Whited, George L Jackson, Heather A King, Sara B Peracca, A Rani Elwy, Julia C Prentice

Abstract

Introduction: Teledermatology has emerged as an important strategy to enhance access to high-quality skin care. VA Telederm is a provider-facing, web-based mobile app designed to integrate into the existing teledermatology workflow in the US Veterans Health Administration (VHA). In this study, we will conduct a systematic evaluation of VA Telederm on access outcomes in VHA facilities using a pragmatic trial guided by clinical and operational leaders.

Methods and analysis: The study is a prospective, stepped-wedge cluster randomised trial with cross-sectional exposure and outcome measurement via retrospective database analysis of administrative records. Each cluster is a VHA facility deemed eligible for the trial. We assign the intervention using a cluster-level balanced randomisation scheme based on facility size, baseline teledermatology uptake and geographic location. The trial will test whether patients receiving dermatological care at participating facilities will have better access compared with patients receiving care through the current standard process. The primary outcomes proxy for patient-level access to dermatology services, including (1) consult completion time for teledermatology consults; (2) appointment completion time for new dermatology consults; and (3) travel distance for dermatology services. As secondary outcomes, we will assess facility-level adoption outcomes, that is, the number of dermatology encounters and the proportion of teledermatology consults out of all dermatology encounters. To account for secular trends in outcomes and for correlation across individuals within clusters, we will assess the impact of the intervention using generalised linear mixed regression models.

Discussion: Streamlining the current practice for store-and-forward teledermatology in the VHA can improve access to expert dermatological care for US veterans. The lessons learnt in this trial could validate the use of mobile technology for consultative store-and-forward dermatology in a large healthcare organisation. The results may also be of interest to other medical specialties assessing the merits of implementing mobile telehealth.

Protocol version: Version 3; 7 November 2018.

Trial registration number: NCT03241589; Pre-results.

Keywords: dermatology; organisation of health services; telemedicine.

Conflict of interest statement

Competing interests: JDW declares that he receives royalties based on sales as coeditor of ’Teledermatology: a User’s Guide', Cambridge University Press 2008. No other authors declare any conflict of interest.

© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Current workstation-based teledermatology process in the Veterans Health Administration (VHA).
Figure 2
Figure 2
Timeline and design features for the VA Telederm stepped-wedge cluster randomised trial (SW-CRT).

References

    1. Coates SJ, Kvedar J, Granstein RD. Teledermatology: from historical perspective to emerging techniques of the modern era: part I: History, rationale, and current practice. J Am Acad Dermatol 2015;72:563–74. 10.1016/j.jaad.2014.07.061
    1. Kimball AB, Resneck JS. The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol 2008;59:741–5. 10.1016/j.jaad.2008.06.037
    1. Yoo JY, Rigel DS. Trends in dermatology: geographic density of US dermatologists. Arch Dermatol 2010;146:779 10.1001/archdermatol.2010.127
    1. Nelson CA, Takeshita J, Wanat KA, et al. . Impact of store-and-forward (SAF) teledermatology on outpatient dermatologic care: A prospective study in an underserved urban primary care setting. J Am Acad Dermatol 2016;74:484–90. 10.1016/j.jaad.2015.09.058
    1. Uscher-Pines L, Malsberger R, Burgette L, et al. . Effect of teledermatology on access to dermatology care among medicaid enrollees. JAMA Dermatol 2016;152:905–12. 10.1001/jamadermatol.2016.0938
    1. Hsiao JL, Oh DH. The impact of store-and-forward teledermatology on skin cancer diagnosis and treatment. J Am Acad Dermatol 2008;59:260–7. 10.1016/j.jaad.2008.04.011
    1. van der Heijden JP, de Keizer NF, Bos JD, et al. . Teledermatology applied following patient selection by general practitioners in daily practice improves efficiency and quality of care at lower cost. Br J Dermatol 2011;165:1058–65. 10.1111/j.1365-2133.2011.10509.x
    1. Leavitt ER, Kessler S, Pun S, et al. . Teledermatology as a tool to improve access to care for medically underserved populations: A retrospective descriptive study. J Am Acad Dermatol 2016;75:1259–61. 10.1016/j.jaad.2016.07.043
    1. Piette E, Nougairède M, Vuong V, et al. . Impact of a store-and-forward teledermatology intervention versus usual care on delay before beginning treatment: A pragmatic cluster-randomized trial in ambulatory care. J Telemed Telecare 2017;23:725–32. 10.1177/1357633X16663328
    1. Whited JD, Hall RP, Foy ME, et al. . Teledermatology’s impact on time to intervention among referrals to a dermatology consult service. Telemed J E Health 2002;8:313–21. 10.1089/15305620260353207
    1. Department of Veterans Affairs. Expanded Access to Non-VA Care Through the Veterans Choice Program. Interim final rule. Fed Regist 2015;80:74991–6.
    1. Shulkin DJ. Beyond the VA Crisis-becoming a high-performance network. N Engl J Med 2016;374:1003–5. 10.1056/NEJMp1600307
    1. Lee J, Capra G, Klobucar T. Forging new paths to integrate rural veterans’ care nationwide: Integrate rural veterans’ care. J Rural Health 2016;32:374–6.
    1. Landow SM, Oh DH, Weinstock MA. Teledermatology within the veterans health administration, 2002-2014. Telemed J E Health 2015;21:769–73. 10.1089/tmj.2014.0225
    1. McFarland LV, Raugi GJ, Reiber GE. Primary care provider and imaging technician satisfaction with a teledermatology project in rural Veterans Health Administration clinics. Telemed J E Health 2013;19:815–25. 10.1089/tmj.2012.0327
    1. McFarland LV, Raugi GJ, Taylor LL, et al. . Implementation of an education and skills programme in a teledermatology project for rural veterans. J Telemed Telecare 2012;18:66–71. 10.1258/jtt.2011.110518
    1. Raugi GJ, Nelson W, Miethke M, et al. . Teledermatology implementation in a VHA secondary treatment facility improves access to face-to-face care. Telemedicine and e-Health 2016;22:12–17. 10.1089/tmj.2015.0036
    1. Atkins D, Kilbourne AM, Shulkin D. Moving from discovery to system-wide change: The role of research in a learning health care system: Experience from three decades of health systems research in the veterans health administration. Annu Rev Public Health 2017;38:467–87. 10.1146/annurev-publhealth-031816-044255
    1. Kilbourne AM, Elwy AR, Sales AE, et al. . Accelerating research impact in a learning health care system: Va’s quality enhancement research initiative in the choice act era. Med Care 2017;55 Suppl 7 Suppl 1:S4–S12. 10.1097/MLR.0000000000000683
    1. Chan AW, Tetzlaff JM, Altman DG, et al. . SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Chan AW, Tetzlaff JM, Gøtzsche PC, et al. . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586 10.1136/bmj.e7586
    1. Copas AJ, Lewis JJ, Thompson JA, et al. . Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches. Trials 2015;16:352 10.1186/s13063-015-0842-7
    1. Davey C, Hargreaves J, Thompson JA, et al. . Analysis and reporting of stepped wedge randomised controlled trials: synthesis and critical appraisal of published studies, 2010 to 2014. Trials 2015;16:358 10.1186/s13063-015-0838-3
    1. Hemming K, Taljaard M, Forbes A. Analysis of cluster randomised stepped wedge trials with repeated cross-sectional samples. Trials 2017;18:101 10.1186/s13063-017-1833-7
    1. Kilbourne AM, Neumann MS, Pincus HA, et al. . Implementing evidence-based interventions in health care: application of the replicating effective programs framework. Implement Sci 2007;2:42 10.1186/1748-5908-2-42
    1. Neumann MS, Sogolow ED. Replicating effective progams: HIV/AIDS prevention technology transfer. AIDS Educ Prev N Y 2000;12:35–48.
    1. Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, et al. . A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework. Health Res Policy Syst 2015;13:16 10.1186/s12961-015-0005-z
    1. Klein KJ, Sorra JS. The challenge of innovation implementation. Acad Manage Rev 1996;21:1055–80. 10.5465/amr.1996.9704071863
    1. Weiner BJ, Lewis MA, Linnan LA. Using organization theory to understand the determinants of effective implementation of worksite health promotion programs. Health Educ Res 2009;24:292–305. 10.1093/her/cyn019
    1. Klein KJ, Conn AB, Sorra JS. Implementing computerized technology: an organizational analysis. J Appl Psychol 2001;86:811–24. 10.1037/0021-9010.86.5.811
    1. Helfrich CD, Weiner BJ, McKinney MM, et al. . Determinants of implementation effectiveness: adapting a framework for complex innovations. Med Care Res Rev 2007;64:279–303. 10.1177/1077558707299887
    1. Weiner BJ. A theory of organizational readiness for change. Implement Sci 2009;4:67 10.1186/1748-5908-4-67
    1. Shaw RJ, Kaufman MA, Bosworth HB, et al. . Organizational factors associated with readiness to implement and translate a primary care based telemedicine behavioral program to improve blood pressure control: the HTN-IMPROVE study. Implement Sci 2013;8:106 10.1186/1748-5908-8-106
    1. Shea CM, Jacobs SR, Esserman DA, et al. . Organizational readiness for implementing change: a psychometric assessment of a new measure. Implement Sci 2014;9:7 10.1186/1748-5908-9-7
    1. Chamberlain P, Brown CH, Saldana L. Observational measure of implementation progress in community based settings: the Stages of Implementation Completion (SIC). Implement Sci 2011;6:116 10.1186/1748-5908-6-116
    1. Mancini JA, Marek LI. Sustaining community-based programs for families: Conceptualization and measurement*. Fam Relat 2004;53:339–47. 10.1111/j.0197-6664.2004.00040.x
    1. Stolldorf DP. Sustaining health care interventions to achieve quality care: What we can learn from rapid response teams. J Nurs Care Qual 2017;32:87–93. 10.1097/NCQ.0000000000000204
    1. Fisher RA. An examination of the different possible solutions of a problem in incomplete blocks. Ann Eugen 1940;10:52–75. 10.1111/j.1469-1809.1940.tb02237.x
    1. Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol 2006;6:54 10.1186/1471-2288-6-54
    1. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 2007;28:182–91. 10.1016/j.cct.2006.05.007
    1. Hemming K. & Girling, A. J. A menu-driven facility for power and detectable-difference calculations in stepped-wedge cluster-randomized trials. Stata J 2014;14:363–80.
    1. Baio G. SWSamp: Simulation-based sample size calculations for a Stepped Wedge Trial (and more), 2016.
    1. Bertsimas D, Johnson M, Kallus N. The power of optimization over randomization in designing experiments involving small samples. Oper Res 2015;63:868–76. 10.1287/opre.2015.1361
    1. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103.
    1. Department of Veterans Affairs. REquirements for the protection of human subjects in research. 2014. VHA Handbook 1200.05.
    1. Weijer C, Grimshaw JM, Eccles MP, et al. . THe ottawa statement on the ethical design and conduct of cluster randomized trials. PLoS Med 2012;9:e1001346 10.1371/journal.pmed.1001346
    1. Pizer SD, Davies ML, Prentice JC. Consult timeliness strongly predicts patient satisfaction. Am J Accountable Care In Press 2016.
    1. Prentice JC, Davies ML, Pizer SD. Which outpatient wait-time measures are related to patient satisfaction? Am J Med Qual 2014;29:227–35. 10.1177/1062860613494750

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren